Diagnostic value and implications of vimentin expression in normal, reactive and neoplastic endocervical epithelium

Pathology

Volumn 42, Issue 3, 2010, Pages 217-223

  Stewart, C J R ^a,b   Little, L ^a,b  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Adenocarcinoma; Cervix; Immunohistochemistry; Invasion; Vimentin

Indexed keywords

EID: 77950337412     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.3109/00313021003631353     Document Type: Article

References (44)

1. Schorge JO, Knowles LM, Lea JS. Adenocarcinoma of the cervix. Curr Treat Options Oncol 2004; 5: 119-127
2. Bray F, Carstensen B, Moller H, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev 2005; 14: 2191-2199
3. Vizcaino AP, Moreno V, Bosch FX, Munoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer: 1. Adenocarcinoma and adenosquamous carcinoma. Int J Cancer 1998; 75: 536-545
4. Sasieni P, Castanon A, Cuzick J. Screening and adenocarcinoma of the cervix. Int J Cancer 2009; 125: 525-529
5. Zaino RJ. Symposium part I: adenocarcinoma in situ, glandular dysplasia, and early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2002; 21: 314-326
6. Young RH, Clement PB. Pseudoneoplastic glandular lesions of the uterine cervix. Semin Diagn Pathol 1991; 8: 234-249
7. Nucci MR. Symposium part III: tumor-like glandular lesions of the uterine cervix. Int J Gynecol Pathol 2002; 21: 347-359
8. Suh K-S, Silverberg SG. Tubal metaplasia of the uterine cervix. Int J Gynecol Pathol 1990; 9: 122-128
9. Ismail SM. Cone biopsy causes cervical endometriosis and tuboendometrioid metaplasia. Histopathology 1991; 18: 107-114
10. Oliva E, Clement PB, Young RH. Tubal and tubo-endometrioid metaplasia of the uterine cervix: unemphasized features that may cause problems in differential diagnosis - a report of 25 cases. Am J Clin Pathol 1995; 103: 618-623
11. McCluggage WG, Maxwell P, McBride HA, Hamiliton PW, Bharucha H. Monoclonal antibodies Ki-67 and MIB1 in the distinction of tuboendometrial metaplasia from endocervical adenocarcinoma and adenocarcinoma in situ in formalin-fixed material. Int J Gynecol Pathol 1995; 14: 209-216
12. Cameron RI, Maxwell P, Jenkins D, McCluggage WG. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia. Histopathology 2002; 41: 313-321
13. Riethdorf L, Riethdorf S, Lee KR, Cviko A, Loning T, Crum CP. Human papillomaviruses, expression of p16INK4A and early endocervical glandular neoplasia. Hum Pathol 2002; 33: 899-904.
14. Negri G, Egarter-Vigl E, Kasal A, Romano F, Haitel A, Mian C. p16INK4a is a useful marker for the diagnosis of adenocarcinoma of the cervix uteri and its precursors: an immunohistochemical study with immunocytochemical correlations. Am J Surg Pathol 2003; 27: 187-193
15. Murphy N, Heffron CCBB, King B, et al. P16INK4A positivity in benign, premalignant and malignant cervical glandular lesions: a potential diagnostic problem. Virchows Arch 2004; 445: 610-615
16. Tringler B, Gup CJ, Singh M, et al. Evaluation of p16INK4a and pRb expression in cervical squamous and glandular neoplasia. Hum Pathol 2004; 35: 689-696
17. O'Neill CJ, McCluggage WG. p16 expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006; 13: 8-15.
18. McCluggage WG. Immunohistochemistry as a diagnostic aid in cervical pathology. Pathology 2007; 39: 97-111.
19. Park KJ, Soslow RA. Current concepts in cervical pathology. Arch Pathol Lab Med 2009; 133: 729-738
20. Roh MH, Agoston E, Birch C, Crum CP. P16 immunostaining patterns in microglandular hyperplasia of the cervix and their significance. Int J Gynecol Pathol 2009; 28: 107-113
21. Mulvaney NJ, Allen DG, Wislon SM. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008; 40: 335-344
22. Park JJ, Sun D, Quade BJ, et al. Stratified mucin-producing intraepithelial lesions of the cervix: adenosquamous or columnar cell neoplasia? Am J Surg Pathol 2000; 24: 1414-1419
23. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002; 41: 185-207.
24. Guarino M, Rubino B, Ballabio G. The role of epithelial-mesenchymal transition in cancer pathology. Pathology 2007; 39: 305-318
25. Hugo H, Ackland ML, Blick T, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374-383
26. Dabbs DJ, Geisinger KR, Norris TH. Intermediate filaments in endometrial and endocervical carcinomas. The diagnostic utility of vimentin patterns. Am J Surg Pathol 1986; 10: 568-576
27. Ohwada M, Suzuki M, Tamada T. Immunohistochemical investigation of vimentin of uterine endometrial and endocervical adenocarcinoma. Nippon Sanka Fujinka Gakkai Zasshi 1990; 42: 1237-1243
28. Dabbs DJ, Sturtz K, Zaino RJ. The immunohistochemical discrimination of endometrioid adenocarcinomas. Hum Pathol 1996; 27: 172-177
29. Castrillon DH, Lee KR, Nucci MR. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 2001; 21: 4-10.
30. McCluggage WG, Sumathi VP, McBride HA, Patterson A. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002; 21: 11-15
31. Alkushi A, Irving J, Hsu F, et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003; 442: 271-277
32. Puts JJG, Moesker O, Kenemans P, Vooijs GP, Ramaekers CS. Expression of cytokeratins in early neoplastic epithelial lesions of the uterine cervix. Int J Gynecol Pathol 1985; 4: 300-313
33. Lang G, Dallenbach-Hellweg G. The histogenetic origin of cervical mesonephric hyperplasia and mesonephric adenocarcinoma of the uterine cervix studied with immunohistochemical methods. Int J Gynecol Pathol 1990; 9: 145-157.
34. Qiu W, Mittal K. Comparison of morphologic and immunohistochemical features of cervical microglandular hyperplasia with low-grade mucinous adenocarcinoma of the endometrium. Int J Gynecol Pathol 2003; 22: 261-265
35. Chekmareva M, Ellenson LH, Pirog EC. Immunohistochemical differences between mucinous and microglandular adenocarcinomas of the endometrium and benign endocervical epithelium. Int J Gynecol Pathol 2008; 27: 547-554
36. Puts JJG, Moesker O, de Waal RMW, Kenemans P, Vooijs GP, Ramaekers CS. Immunohistochemical identification of Langerhans cells in normal epithelium and in epithelial lesions of the uterine cervix. Int J Gynecol Pathol 1986; 5: 151-162
37. Marques T, Andrade LA, Vassallo J. Endocervical tubal metaplasia and adenocarcinoma in situ: role of immunohistochemistry for carcinoembryonic antigen and vimentin in differential diagnosis. Histopathology 1996; 28: 549-550
38. Eriksson JE, Dechat T, Grin B, et al. Introducing intermediate filaments: from discovery to disease. J Clin Invest 2009; 119: 1763-1771
39. Kim S, Coulombe PA. Intermediate filament scaffolds fulfil mechanical, organizational, and signalling functions in the cytoplasm. Genes Develop 2007; 21: 1581-1597
40. Hendrix MJ, Seftor EA, Chu YW, Trevor KT, Seftor RE. Role of intermediate filaments in migration, invasion and metastasis. Cancer Metastasis Rev 1996; 15: 507-525
41. Tamimi HK, Gown AM, Kim-Deobald J, Figge DC, Greer BE, Cain JM. The utility of immunocytochemistry in invasive adenocarcinoma of the cervix. Am J Obstet Gynecol 1992; 166: 1655-1662
42. Kamoi S, Al Juboury MI, Akin MR, Silverberg SG. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol 2002; 21: 217-223
43. Stewart CJR, Little L. Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelialmesenchymal transition. Histopathology 2009; 55: 91-101.
44. Stewart CJR, Crook ML, Leung YC, Platten M. Expression of cell cycle regulatory proteins in endometrial adenocarcinoma: variations in conventional tumor areas and in microcystic, elongated and fragmented glands. Mod Pathol 2009; 22: 725-733